News Links
Daily Care News from March 7, 2018
Real-World Use of Open Source Artificial Pancreas Systems. Free full text available in PDF format. Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast-acting insulin aspart compared to insulin aspart. Automatic Adaptation of Basal Insulin Using Sensor-Augmented Pump Therapy. Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII Treatment. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Young children with type 1 diabetes can achieve glycemic targets without hypoglycemia: Results of a novel intensive diabetes management program. Advancing diabetes […]
Read MoreResearch News From March 7, 2018
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. See also Diabetes is actually five separate diseases, research suggests. A prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycemia in adults with type 1 diabetes in a real-world setting. Seasonal Variation in Month of Diagnosis of Polish Children with Type 1 Diabetes – A Multicenter Study. Preventing Nocturnal Hypoglycemia: Single- vs Dual-Hormone Artificial Pancreas System. Safety and Efficacy of Epigenetically Converted Human Fibroblasts Into Insulin-Secreting Cells: A Preclinical Study.
Read MorePopular Press from February 28, 2018
Woman raises concerns over diabetes alert dog agency. Type 1 diabetes: A life-changing diagnosis. Roche’s Sinking Diabetes Unit Looks Toward a Monster for a Boost. Thomy toolkit could make life easier for children with type-1 diabetes.
Read MoreLegislative and Policy News from February 28, 2018
Emergency Prescription Refill Bill Signed Into Law. Injections a sticking point in schools for students with diabetes.
Read MoreCeliac News from February 28, 2018
Safety of Oats in Children with Celiac Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. Dietary Patterns After the Weaning and Lactation Period Associate with Celiac Disease Autoimmunity in Children. Gut microbiota trajectory in early life may predict development of celiac disease. Free full text available in HTML and PDF formats. Endoplasmic reticulum–resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2. See also Looking for an off switch for celiac disease, Researchers discover a new enzyme that treats celiac disease, and Researchers Discover Protein Activity That Could Treat Gluten Intolerance and Celiac Disease.
Read MoreDaily Care News from February 28, 2018
Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study. Free full text available in HTML and PDF formats. Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis. Impact of type 1 diabetes on maternal long-term risk of hospitalisation and mortality: a nationwide combined clinical and register-based cohort study (The EPICOM study). Association between […]
Read MoreResearch News From February 28, 2018
Clustering of microvascular complications in Type 1 diabetes mellitus. Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy.
Read MorePress Releases from February 21, 2018
Insulet Has Strong Presence at the International ATTD Congress; Presents Positive Study Results for Its Omnipod Horizon™ Hybrid Closed-Loop System. Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Care’s Pivotal Trial for the t:slim X2 Insulin Pump with Predictive Low Glucose Suspend Feature; Data to be Presented at ATTD 2018 Conference. New Study Demonstrates that DexCom CGM Significantly Reduces Hypoglycaemia in People with Type 1 Diabetes on MDI. Tandem Diabetes Care Applies for Health Canada Medical Device License. Tackling the Cell Supply Challenge Takes Center Stage in Spain as DRI’s Dr. Juan Dominguez-Bendala Discusses Potential Breakthroughs. Zealand Pharma’s dasiglucagon Phase […]
Read More